IL-17 inhibition: is it the long-awaited savior for alopecia areata?
- 1 March 2018
- journal article
- review article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 310 (5) , 383-390
Abstract
Interleukin-17 (IL-17) has been implicated in the pathogenesis of a large number of inflammatory and autoimmune conditions, including skin disorders such as psoriasis. Recently, much data have accumulated on the possible role of IL-17 in the pathogenesis of alopecia areata (AA). In this review, the available information on the connection between AA and IL-17 is described. While IL-17 levels are consistently reported to be elevated in the serum and lesional skin of AA patients, there is no clear connection between IL-17 levels and disease severity or duration. Some evidence has suggested an association between IL-17 and an early-onset disease, although this awaits further confirmation. While there is enough information to support clinical trials with IL-17-targeted treatments, it is possible that they will be effective only in a subset of AA patients. Further studies are warranted to better delineate the exact role of IL-17 in AA pathogenesis.Keywords
This publication has 110 references indexed in Scilit:
- Alopecia Areata: a Comprehensive Review of Pathogenesis and ManagementClinical Reviews in Allergy & Immunology, 2017
- The Changing Landscape of Alopecia Areata: The Translational LandscapeAdvances in Therapy, 2017
- The Changing Landscape of Alopecia Areata: The Therapeutic ParadigmAdvances in Therapy, 2017
- Ixekizumab for the Treatment of Psoriasis: A Review of Phase III TrialsDermatology and Therapy, 2016
- B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia AreataArchives of Dermatological Research, 2016
- Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilageEuropean Journal of Immunology, 2015
- Chronic exposure to stress predisposes to higher autoimmune susceptibility in C57BL/6 mice: Glucocorticoids as a double‐edged swordEuropean Journal of Immunology, 2012
- IL‐17: A new actor in IFN‐driven systemic autoimmune diseasesEuropean Journal of Immunology, 2012
- Distinct regulation of interleukin‐17 in human T helper lymphocytesArthritis & Rheumatism, 2007
- Treatment with a neutralizing anti‐murine interleukin‐17 antibody after the onset of collagen‐induced arthritis reduces joint inflammation, cartilage destruction, and bone erosionArthritis & Rheumatism, 2004